Clinical Trial Update: A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

View source ↗

Summary

This document summarizes an update on a non-interventional trial of erlotinib (Tarceva) for metastatic non-small cell lung cancer, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2016-01-25